Material Type

• Blood (whole) (3)
• Buffy coat (1)
• Cerebrospinal fluid (1)
• Dried whole blood (3)
• Isolated peripheral blood mononuclear cells (non viable) (1)
• Plasma (single spun) (4)
• Saliva (3)
• Serum (4)
• Swab medium (6)
• Urine (random) (2)

Microscopic Assessment

• Affected (1)
• Non-affected (2)
• Not applicable (7)

Storage Temperature

• RT (1)
• -35°C to -18°C (4)
• -85°C to -60°C (4)

Preservation Type

• N/A (1)

Associated Data

• Biomarker datasets (2)
• Clinical records (6)
• Followup records (4)
• Freezer temperature logs (4)
• Imaging data (3)
• Microbiological results (5)
• Participant Ethnicity (1)
• Physiological/biochemical measurements (3)
• Pre-analytical data (5)
• Primary care records (1)
• Quality indicators (4)
• Survey data (5)
• Treatment records (1)

Timeframe

• Immediate (4)
• 0 - 3 months (6)
• 3 - 6 months (2)
• > 6 months (3)

Participant Count

• 11 - 100 (4)
• 101 - 500 (3)
• 501 - 1000 (1)
• 1001 - 3000 (1)

Sex

• Unknown (1)
• Both sexes (8)

Age Range

• Young adult (18 - 40 years) (9)

Biobank Services

• Ability to recontact (3)
• Cell culture (1)
• Data analytics (3)
• Infectious strain isolation (3)
• Molecular Extractions (1)
• Nucleic acid extraction (3)

Collection Type

• Disease specific (9)

Consent Restriction

• No Commercial restriction (3)
• No Disease area restriction (9)
• No Genetic analysis restriction (5)
• No Human genetic analysis restriction (4)
• No restrictions (0)
• No Project specific restriction (9)
• No Scope of use restriction (6)

Collection Status

• Completed (3)
• In progress (6)

Access Condition

• Open to applicants (3)
• Open only through collaboration (2)
• Access restricted at present (3)
• Closed to access (1)

Country

• Brazil (1)
• Cameroon (1)
• Côte d'Ivoire (1)
• France (1)
• Ghana (1)
• Peru (1)
• South Africa (1)
• Uganda (1)
• United Kingdom of Great Britain and Northern Ireland (1)

County